Condition
Filarial Infection
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT00344279CompletedPrimary
Changes in HIV Viral Load in Patients Undergoing Treatment for Filariasis
NCT00342017Completed
The Effect of Parasitic Worm Infections on the Immune Response to Tuberculosis Bacteria
NCT00341666Completed
Immune Response Regulation in People Infected Concurrently With Malarial and Filarial Parasites
Showing all 3 trials